肝癌肝移植热点问题探讨
Discussion on hot issues in liver transplantation for hepatocellular carcinoma
-
摘要: 我国是肝病大国,原发性肝癌发病人数和死亡人数均位居世界前列。作为肝癌的治愈性治疗手段之一,肝移植已经成为肝脏外科的一项重要技术。多数肝癌患者确诊时已进展为巴塞罗那临床肝癌分期B期或C期,如何降低肝癌患者在等待肝移植期间因肝肿瘤进展导致的脱失率,制订肝移植后个体化的免疫抑制剂方案,通过精准化管理预防肝癌肝移植后肿瘤复发是目前研究的热点。笔者查阅相关文献,总结团队治疗经验,探讨肝癌肝移植相关热点问题,旨在为肝癌治疗提供参考。Abstract: Liver diseases are common in China and the incidence and mortality of primary liver cancer are among the top in the world. As one of the therapeutic methods for hepatocellular carcinoma (HCC), liver transplantation has become an important technique in hepatic surgery. Most of patients with HCC have progressed to stage B or C of Barcelona Clinic Liver Cancer staging when diagnosed. How to reduce the dropout rate of HCC patients due to the progression of tumor when waiting for liver transplantation, develop individualized immunosuppressant plans for HCC patients after liver transplantation, and accurately manage patients with HCC recurrence after liver transplan-tation are the current hotspots of research. The authors review the relevant literature, summarize the treatment experience, and discuss the hot issues in liver transplantation for HCC, in order to provide reference for related treatment.